Clinical research services firm Javara, known to promote the model known as “Clinical Research as a Care Option” has worked furiously over the past couple years to build up a viable business. The firm inked a handful of prominent clincial research contracts, such as Wake Forest Baptist Health; and most recently, their business model was validated by the securing of $4.6 million in new investor commitments. Apparently, eleven investors have come together following a $3.7 million investment last year.
A Solid Board & Individual Investors
Investors/Board members include Charles Hauser, a prominent business executive active in the life sciences arena in Northern California. Hauser co-founded Piedmont Medical Research Associates (PMG Research Inc, which was acquired by ICON) as well as Physician Discoveries LLC and other ventures. Jeffrey Kasher, also an independent board member, brings an impressive, lengthy background out of the pharma industry, including Eli Lilly. He also is the CEO of Patients Can’t Wait. John Vann spent years driving growth for contract research organization (CRO) Chiltern and also joined the Board of PMG research until its acquisition; John is a member...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).